Combination therapy with erlotinib and cisplatin is effective in patients with recurrent or metastatic squamous cell cancer of the head and neck

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1591, 2007-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3940-3951

Blackwell Publishing

Access to resources Recommend Favorite

Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal

By Bagust Adrian  

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 439-448

Adis International

Access to resources Recommend Favorite

Topoisomerases in the treatment of metastatic or recurrent squamous carcinoma of the head and neck

By Murphy Barbara A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 85-92

Informa Healthcare

Access to resources Recommend Favorite

Combination gemcitabine + cisplatin therapy for recurrent ovarian cancer

By  

Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck and Metastatic Colorectal Cancer

By Blick Stephanie K.A.   Scott Lesley J.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2585-2607

Adis International

Access to resources Recommend Favorite